Nitrogen may serve as a protective atmosphere, transfer gas or packaging gas in certain manufacturing steps. Gas directly contacting a product or the inside of primary packaging requires a different assessment from gas serving auxiliary equipment only. Sterile and non-sterile processes also require separate consideration. The pharmaceutical manufacturer's quality and process teams should own the specification.
Residual oxygen measurement alone does not establish the full composition or cleanliness of the gas. Define moisture, oil, particles, relevant chemical contaminants and required microbiological quality according to use. State units, limits, sampling locations, methods and frequency for each parameter. The quality team determines applicable pharmacopoeial or product requirements; there is no universal ppm value for every process.
EU GMP Annex 1 addresses point-of-use sterilising filtration, appropriate integrity checks and microbial monitoring for aseptic gas use. High purity, or a PSA generator alone, does not guarantee sterile gas. The condition of pipework downstream of the final filter also belongs within the validated hygiene approach. This guide does not replace the site's quality approval.
Gas meeting requirements at the generator may not retain that quality through storage and distribution. Assess receivers, pipes, regulators and sampling arrangements together, including backflow and contamination after maintenance. Establish sampling plans for commissioning, restart and change control. Define the assessment of affected production after an alarm and the conditions for returning gas to service through the site's quality procedures.
Review the nitrogen generation scope with Mentis Engineering against your pharmaceutical site's approved gas specification and point-of-use requirements.
